Adherence to WCRF/AICR cancer prevention recommendations and risk of postmenopausal breast cancer.

Cancer Epidemiol Biomarkers Prev

Fred Hutchinson Cancer Research Center; Department of Epidemiology, University of Washington, Seattle, Washington, USA.

Published: September 2013

Background: In 2007, the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) released eight recommendations related to body fatness, physical activity, and diet aimed at preventing the most common cancers worldwide. However, limited information exists on the association between meeting these recommendations and risks of specific cancers, including breast cancer.

Methods: We operationalized six recommendations (related to body fatness, physical activity, foods that promote weight gain, plant foods, red and processed meats, and alcohol) and examined their association with invasive breast cancer incidence over 6.7 years of follow-up in the Vitamins and Lifestyle (VITAL) study cohort. Participants included 30,797 postmenopausal women, ages 50-76 years at baseline in 2000-2002 with no history of breast cancer. Breast cancers (n = 899) were tracked through the Western Washington Surveillance, Epidemiology, and End Results database.

Results: Breast cancer risk was reduced by 60% in women who met at least five recommendations compared with those who met none [HR: 0.40; 95% confidence interval (CI): 0.25-0.65; Ptrend < 0.001]. Further analyses that sequentially removed individual recommendations least associated with reduced risk suggested that this reduction is due to meeting recommendations related to body fatness, plant foods, and alcohol (HR for meeting vs. not meeting these three recommendations: 0.38; 95% CI: 0.25-0.58; Ptrend < 0.001).

Conclusions: Meeting the WCRF/AICR cancer prevention recommendations, specifically those related to alcohol, body fatness, and plant foods, is associated with reduced postmenopausal breast cancer incidence.

Impact: Increased adherence to the WCRF/AICR cancer prevention recommendations could substantially reduce postmenopausal breast cancer risk in U.S. women.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774119PMC
http://dx.doi.org/10.1158/1055-9965.EPI-13-0210DOI Listing

Publication Analysis

Top Keywords

breast cancer
24
body fatness
16
wcrf/aicr cancer
12
cancer prevention
12
prevention recommendations
12
postmenopausal breast
12
recommendations body
12
plant foods
12
cancer
11
recommendations
10

Similar Publications

Gymnostachyum febrifugum, a less-known ethnomedicinal plant from the Western Ghats of India, is used to treat various diseases and serves as an antioxidant and antibacterial herb. The present study aims to profile the cytotoxic phytochemicals in G. febrifugum roots using GC-MS/MS, in vitro confirmation of cytotoxic potential against breast cancer and an in silico study to understand the mechanism of action.

View Article and Find Full Text PDF

Objectives: The aim is to assess the feasibility and accuracy of a novel quantitative ultrasound (US) method based on global speed-of-sound (g-SoS) measurement using conventional US machines, for breast density assessment in comparison to mammographic ACR (m-ACR) categories.

Materials And Methods: In a prospective study, g-SoS was assessed in the upper-outer breast quadrant of 100 women, with 92 of them also having m-ACR assessed by two radiologists across the entire breast. For g-SoS, ultrasonic waves were transmitted from varying transducer locations and the image misalignments between these were then related analytically to breast SoS.

View Article and Find Full Text PDF

Unraveling the potential mechanism and prognostic value of pentose phosphate pathway in hepatocellular carcinoma: a comprehensive analysis integrating bulk transcriptomics and single-cell sequencing data.

Funct Integr Genomics

January 2025

Institute of Infectious Diseases, Guangdong Province, Guangzhou Eighth People's Hospital, Guangzhou Medical University, 8 Huaying Road, Baiyun District, Guangzhou, 510440, China.

Hepatocellular carcinoma (HCC) remains a malignant and life-threatening tumor with an extremely poor prognosis, posing a significant global health challenge. Despite the continuous emergence of novel therapeutic agents, patients exhibit substantial heterogeneity in their responses to anti-tumor drugs and overall prognosis. The pentose phosphate pathway (PPP) is highly activated in various tumor cells and plays a pivotal role in tumor metabolic reprogramming.

View Article and Find Full Text PDF

Knockdown of miR-182 changes the sensitivity of triple-negative breast cancer cells to cisplatin.

Nucleosides Nucleotides Nucleic Acids

January 2025

Division of Hematology, Department of Internal Medicine, Medical Faculty, Tekirdağ Namık Kemal University, Tekirdağ, Turkey.

Breast cancer is the most common malignancy that affects women. MicroRNAs (miRNAs) play an essential role in cancer therapy and regulate many biological processes such as cisplatin resistance. The study's objective was to determine whether miR-182 dysregulation was the cause of cisplatin resistance in TNBC cell line MDA-MB-231.

View Article and Find Full Text PDF

TP53 mutations and MDM2 polymorphisms in breast and ovarian cancers: amelioration by drugs and natural compounds.

Clin Transl Oncol

January 2025

Inflammation and Cancer Biology Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, Assam, 784028, India.

Globally, breast and ovarian cancers are major health concerns in women and account for significantly high cancer-related mortality rates. Dysregulations and mutations in genes like TP53, BRCA1/2, KRAS and PTEN increase susceptibility towards cancer. Here, we discuss the impact of mutations in the key regulatory gene, TP53 and polymorphisms in its negative regulator MDM2 which are reported to accelerate cancer progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!